Thin Structural Design Concomitating with Greater Deliverability
Racer CC is designed with thinner struts to provide the healing advantage associated with minimal vessel injury and better endothelialisation.
Racer CC with its ideal strut thickness offers optimal strength, flexibility and pushability thus ensuring precise deployment
The trusted stent platform of Racer CC has been steadily optimized with thinner struts and cell design offering better long-term outcomes
In this unique long term analysis at 10 years, Yukon has shown the lowest rate of Definite/ Probable Stent Thrombosis with a significant risk reduction than Cypher (50%) and numerically lower TLR rates as compared to Xience (29%) while maintaining the similar efficacy.
Comparison of clinical outcomes at 10 years in patients treated with new-generationBP-SES versus new-generation PP-EES versus early generation SES.
Unmatched Safety- In Complex Patients Subset
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from 3 randomised trials.
At 4 years, Biodegradable Polymer DES Yukon showed significantly lower rates of Stent Thrombosis compared to Durable Polymer DES in patients with Diabetes Mellitus.
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from 3 randomised trials.
At 4 years, Biodegradable Polymer DES Yukon showed significantly lower rates of Stent Thrombosis compared to Durable Polymer DES in patients with Diabetes Mellitus.
Technical Data
PRODUCT MATRIX / ORDERING INFORMATION*
*Please contact our customer care for available sizes
COMPLIANCE CHART
